$4.20
0.051.20%
At Close: -
$4.15
-0.05-1.19%
After Hours: 7:39 PM EDT
15 minutes delayed
Kiora Pharmaceuticals
KPRXNASDAQ
Kiora Pharmaceuticals (NASDAQ:KPRX) Stock, Analyst Ratings, Price Targets, Predictions
Kiora Pharmaceuticals Inc has a consensus price target of $31.38, established from looking at the 18 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 20, 2024, March 27, 2024, and February 9, 2024. With an average price target of $2 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied -51.81% downside for Kiora Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Maxim Group
Ladenburg Thalmann
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Kiora Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/20/2024 | Buy Now | -51.81% | HC Wainwright & Co. | Yi Chen | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | -51.81% | HC Wainwright & Co. | Yi Chen | $18 → $18 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | -51.81% | HC Wainwright & Co. | Yi Chen | $31.5 → $18 | Maintains | Buy | Get Alert |
| 11/13/2023 | Buy Now | -15.66% | HC Wainwright & Co. | Yi Chen | → $31.5 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2023 | Buy Now | -15.66% | HC Wainwright & Co. | Yi Chen | $18 → $31.5 | Maintains | Buy | Get Alert |
| 08/24/2023 | Buy Now | -51.81% | HC Wainwright & Co. | Yi Chen | → $18 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | Buy Now | -51.81% | HC Wainwright & Co. | Yi Chen | $63 → $18 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | -51.81% | Maxim Group | Michael Okunewitch | $108 → $18 | Maintains | Buy | Get Alert |
| 05/12/2023 | Buy Now | 68.67% | HC Wainwright & Co. | Yi Chen | $54 → $63 | Maintains | Buy | Get Alert |
| 03/24/2023 | Buy Now | 44.58% | HC Wainwright & Co. | Yi Chen | $90 → $54 | Reiterates | → Buy | Get Alert |
| 02/09/2023 | Buy Now | 189.16% | Maxim Group | Michael Okunewitch | → $108 | Upgrade | Hold → Buy | Get Alert |
| 02/08/2023 | Buy Now | 140.96% | HC Wainwright & Co. | Yi Chen | → $90 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | 2767.47% | Ladenburg Thalmann | Matthew Kaplan | → $1071 | Reiterates | → Buy | Get Alert |
| 08/25/2022 | Buy Now | 56.63% | Ladenburg Thalmann | Matthew Kaplan | → $2340 | Initiates | → Buy | Get Alert |
| 08/15/2022 | Buy Now | — | Maxim Group | Michael Okunewitch | — | Downgrade | Buy → Hold | Get Alert |
| 07/11/2022 | Buy Now | -39.76% | HC Wainwright & Co. | Yi Chen | $1080 → $900 | Maintains | Buy | Get Alert |
| 04/19/2022 | Buy Now | -27.71% | HC Wainwright & Co. | Yi Chen | $1800 → $1080 | Maintains | Buy | Get Alert |
| 01/19/2022 | Buy Now | -39.76% | Maxim Group | Jason McCarthy | → $900 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Kiora Pharmaceuticals (KPRX) stock?
The latest price target for Kiora Pharmaceuticals (NASDAQ:KPRX) was reported by HC Wainwright & Co. on May 20, 2024. The analyst firm set a price target for $2.00 expecting KPRX to fall to within 12 months (a possible -51.81% downside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kiora Pharmaceuticals (KPRX)?
The latest analyst rating for Kiora Pharmaceuticals (NASDAQ:KPRX) was provided by HC Wainwright & Co., and Kiora Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Kiora Pharmaceuticals (KPRX)?
The last upgrade for Kiora Pharmaceuticals Inc happened on February 9, 2023 when Maxim Group raised their price target to $12. Maxim Group previously had a hold for Kiora Pharmaceuticals Inc.
When was the last downgrade for Kiora Pharmaceuticals (KPRX)?
The last downgrade for Kiora Pharmaceuticals Inc happened on August 15, 2022 when Maxim Group changed their price target from N/A to N/A for Kiora Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Kiora Pharmaceuticals (KPRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kiora Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kiora Pharmaceuticals was filed on May 20, 2024 so you should expect the next rating to be made available sometime around May 20, 2025.
Is the Analyst Rating Kiora Pharmaceuticals (KPRX) correct?
While ratings are subjective and will change, the latest Kiora Pharmaceuticals (KPRX) rating was a reiterated with a price target of $2.00 to $2.00. The current price Kiora Pharmaceuticals (KPRX) is trading at is $4.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.